FDA may approve a Biologics License Application if the biologic proves to be?

A Biologics License Application (BLA) is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce. For the FDA to approve a BLA, the biologic must demonstrate that it is both safe and effective.

Safety refers to the absence of harmful side effects or adverse events when the biologic is used as intended. Effectiveness indicates that the biologic achieves its intended purpose, such as preventing disease or treating a condition. Only when both of these standards are met can the FDA ensure that the benefits of the biologic outweigh any potential risks to patients.

While other considerations, such as economic viability or general benefit, may play a role in the broader context of drug development and market access, they are not central to the FDA's decision-making process regarding the approval of a biologic. Therefore, safe and effective is the clear standard required for approval of a BLA by the FDA.